The first global assessment of the collateral impact of the COVID-19 pandemic on pregnancy outcomes found a significant increase in stillbirths, maternal deaths, maternal depression, and women requiring surgery for ectopic pregnancy, researchers reported yesterday in The Lancet Global Health.
Since the introduction of the human papillomavirus (HPV) vaccine in 2006, rates of HPV infections among females fell 88% in teens 14 to 19 years and by 81% in those aged 20 to 24 by 2018, according to a study today in Morbidity and Mortality Weekly Report (MMWR).
People with COVID-19 infections who also used the inflammatory bowel disease (IBD) drug infliximab had significantly fewer detectable antibodies than those who used vedolizumab, which treats IBD without the immune suppression, according to a study yesterday in Gut.
The National Institute of Allergy and Infectious Diseases (NIAID) announced yesterday that it has awarded $2.5 million in grants to support research on bacteriophage therapy.
One more Ebola case has been reported from Nzerekore, where the country's latest outbreak has been under way since the middle of February, Ibrahima Soce Fall, MD, assistant director-general for emergency response at the World Health Organization (WHO), said today at a briefing.
A study today in the journal Family Practice reports that a rapid, multi-viral point-of-care test for respiratory infections was easy to use, acceptable to patients and clinicians, and appeared to influence clinical reasoning about antibiotics.
The Centers for Disease Control and Prevention (CDC) confirmed a new case of Listeria monocytogenes in an outbreak associated with queso fresco made by El Abuelito Cheese Inc, raising the total number of cases to 11.
The Guinea outbreak has reached 17 cases, and the CDC has issued public health and travel-related measures.
A survey of US registered dental hygienists reported that 3.1% had been diagnosed as having COVID-19 as of October 2020, according to a Journal of Dental Hygiene study published yesterday. At the time, the study says an estimated 2.3% of the general US population had been infected.
Patients critically ill with COVID-19 infections had significantly lower levels of antibodies against seasonal human coronaviruses (HCoVs) OV43 and HKU1 than those with mild to severe infections, according to a German study published yesterday in the International Journal of Infectious Diseases.
